Provided by Tiger Fintech (Singapore) Pte. Ltd.

Capricor Therapeutics

11.25
+1.6116.70%
Post-market: 11.350.1000+0.89%19:58 EDT
Volume:1.51M
Turnover:16.45M
Market Cap:513.86M
PE:-9.79
High:11.32
Open:10.20
Low:10.20
Close:9.64
Loading ...

Q3 2024 Capricor Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
14 Nov 2024

Oppenheimer Reaffirms Their Buy Rating on Capricor Therapeutics (CAPR)

TIPRANKS
·
14 Nov 2024

Capricor Therapeutics: Strategic Positioning and Financial Stability Drive Buy Rating

TIPRANKS
·
14 Nov 2024

Capricor Therapeutics Advances with Strategic Expansions

TIPRANKS
·
14 Nov 2024

Capricor Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

Capricor Therapeutics (CAPR) Reports Q3 Loss, Misses Revenue Estimates

Zacks
·
14 Nov 2024

Capricor Therapeutics Q3 Net Loss Widens, Revenue Declines From Year-Ago Levels

MT Newswires Live
·
14 Nov 2024

Capricor Therapeutics reports Q3 EPS (38c), consensus (36c)

TIPRANKS
·
14 Nov 2024

Capricor: Q3 Earnings Snapshot

Associated Press Finance
·
14 Nov 2024

Capricor Therapeutics Q3 2024 GAAP EPS $(0.38) Misses $(0.36) Estimate, Sales $2.30M Miss $3.57M Estimate

Benzinga
·
14 Nov 2024

Capricor Therapeutics Q3 Net Income USD -12.6 Million

THOMSON REUTERS
·
14 Nov 2024

Capricor Therapeutics options imply 8.1% move in share price post-earnings

TIPRANKS
·
14 Nov 2024

Capricor Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
12 Nov 2024

Is Capricor Therapeutics (CAPR) Outperforming Other Medical Stocks This Year?

Zacks
·
07 Nov 2024

Prestige Consumer Healthcare (PBH) Meets Q2 Earnings Estimates

Zacks
·
07 Nov 2024

Earnings Preview: Capricor Therapeutics (CAPR) Q3 Earnings Expected to Decline

Zacks
·
05 Nov 2024

BRIEF-Capricor Therapeutics Files Prospectus Relates To Resale By Selling Stockholder Of Up To 2.8 Million Shares Of Common Stock -SEC Filing

Reuters
·
23 Oct 2024

Capricor Therapeutics files to sell 2.8M shares of common stock for holders

TIPRANKS
·
23 Oct 2024

Capricor Therapeutics Files Prospectus Relates to Resale by Selling Stockholder of up to 2.8 Mln Shares of Common Stock -SEC Filing

THOMSON REUTERS
·
23 Oct 2024

Capricor Therapeutics (NASDAQ:CAPR) shareholder returns have been enviable, earning 685% in 5 years

Simply Wall St.
·
23 Oct 2024